Prof. Ponnusamy Saravanan has been appointed as the next editor-in-chief of the RCP’s oldest journal, Clinical Medicine (ClinMed). He will take over from Prof. Anton Emmanuel in January 2024 to lead the ClinMed editorial board and strategically move the journal forward.
Professor Saravanan is a professor and honorary consultant physician in diabetes, endocrinology and metabolism at Warwick Medical School, University of Warwick and George Eliot Hospital, Nuneaton. He is the lead for the diabetes division for the NIHR Clinical Research Network, West Midlands. He is the founder-director of the international Doctoral Training Programme, which focuses on research capacity-building activities in low- and middle-income countries.
He splits his time equally between clinical and research activity. For the past 17 years, Prof Saravanan’s main research focus is understanding the mechanisms and ethnic variations in ‘programming of obesity and cardiometabolic disorders’ as well as ‘precision medicine’. He has published >130 peer-reviewed articles and won several national and international awards. He passionately believes in ‘primordial prevention’ of metabolic disorders and approaches this by focusing on the health of young women and gestational diabetes (GDM).
His team won the prestigious NHS Innovation award in 2015 for individualised diabetes management for South Asians in the UK. He is instrumental in fast-track adoption of newer therapies and technologies in diabetes locally, regionally and nationally. During the COVID-19 pandemic he was instrumental in writing the new RCOG UK screening guidelines for GDM based on his work, which were adopted widely in the UK. He co-led the BABYSTEPS trial – an innovative, combined face-to-face and remote intervention in post-GDM women to improve their physical activity, in collaboration with University of Leicester. He served as an associate editor for many journals prior to taking the role of editor-in-chief for the RCP’s journal Clinical Medicine. He reviews grants and is a board member for funding bodies nationally and internationally.
Click here to read the original press release.
